Impact of clopidogrel in coronary artery bypass grafting [3] (multiple letters)

European Journal of Cardio-thoracic Surgery

Volumn 27, Issue 1, 2005, Pages 176-177

  Shrivastava, Vivek ^a   Akowuah, Enoch ^b   Englberger, Lars ^c   Carrel, Thierry ^c  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bleeding; Clopidogrel; Coronary artery bypass surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; CLOPIDOGREL;

CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; GRAFT PATENCY; HEART INFARCTION; HEART SURGERY; HEMOSTASIS; HUMAN; LETTER; MEDICAL LITERATURE; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL TECHNIQUE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION;

CORONARY ARTERY BYPASS; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; TICLOPIDINE;

EID: 11144338258     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.09.022     Document Type: Letter

References (0)